Harpoon Therapeutics (HARP) Short Interest Ratio & Short Volume → Boost your retirement with these AI payouts (From InvestorPlace) (Ad) Free HARP Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaSustainability Harpoon Therapeutics Short Interest DataCurrent Short Interest538,400 sharesPrevious Short Interest1,160,000 sharesChange Vs. Previous Month-53.59%Dollar Volume Sold Short$12.35 millionShort Interest Ratio0.5 Days to CoverLast Record DateFebruary 29, 2024Outstanding Shares16,932,000 sharesFloat Size12,500,000 sharesShort Percent of Float4.31%Today's Trading Volume0 sharesAverage Trading Volume1,516,200 sharesToday's Volume Vs. Average0% Short Selling Harpoon Therapeutics ? Sign up to receive the latest short interest report for Harpoon Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartHARP Short Interest Over TimeHARP Days to Cover Over TimeHARP Percentage of Float Shorted Over Time Ad InvestorPlaceRead this before you buy AI stocksBREAKING: New "Formula" Could Lead to Huge AI Payouts When you click here and see what Elon Musk's new invention does… Investors — including multiple billionaires — are now tapping into a unique AI secret to pocket huge, consistent payouts. Starting today, you could siphon a new stream of income from this $3 billion pool of cash. Harpoon Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 2/29/2024538,400 shares $12.35 million -53.6%4.3%0.5 $22.94 2/15/20241,160,000 shares $26.02 million +111.8%11.7%1.2 $22.43 1/31/2024547,700 shares $12.23 million +15.2%5.5%0.8 $22.33 1/15/2024475,400 shares $10.65 million -43.5%4.1%0.9 $22.40 12/31/2023841,300 shares $9.57 million +75.4%7.1%2 $11.37 12/15/2023479,700 shares $4.87 million +21.2%4.1%2.3 $10.16 Get the Latest News and Ratings for HARP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Harpoon Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/30/2023395,800 shares $4.20 million +55.0%3.4%2.2 $10.60 11/15/2023255,300 shares $2.22 million +7.2%1.9%1.6 $8.69 10/31/2023238,200 shares $1.20 million +400.4%45.3%2 $5.04 10/15/202347,600 shares $198,492.00 +7.0%1.8%0.5 $4.17 9/30/202344,500 shares $179,335.00 +61.8%1.7%1.2 $4.03 9/15/202327,500 shares $138,875.00 -25.5%1.0%0.8 $5.05 8/31/202336,900 shares $383,760.00 -63.9%1.4%1.3 $10.40 8/15/2023102,100 shares $82,496.80 -34.8%0.4%0.5 $0.81 7/31/2023156,700 shares $122,743.11 +16.8%0.6%0.8 $0.78 7/15/2023134,200 shares $103,334.00 -71.7%0.5%0.7 $0.77 6/30/2023473,300 shares $336,043.00 +10.4%1.9%2.3 $0.71 6/15/2023428,600 shares $318,921.26 +51.5%1.7%2.1 $0.74 5/31/2023283,000 shares $192,440.00 -32.3%1.1%1.3 $0.68 5/15/2023417,700 shares $313,776.24 -45.1%1.7%1.8 $0.75 4/30/2023761,200 shares $445,378.12 +115.5%3.3%2.5 $0.59 4/15/2023353,200 shares $248,299.60 -4.5%1.5%0.9 $0.70 3/31/2023370,000 shares $275,354.00 -4.6%1.7%0.9 $0.74 3/15/2023387,700 shares $294,652.00 +60.6%2.0%0.8 $0.76 2/28/2023241,400 shares $186,940.16 +32.6%1.3%0.1 $0.77 2/15/2023182,000 shares $147,420.00 -53.6%1.0%0.1 $0.81 1/31/2023392,100 shares $423,468.00 +112.6%2.0%0.2 $1.08 1/15/2023184,400 shares $153,420.80 -80.2%1.0%0.1 $0.83 12/30/2022932,300 shares $676,570.11 -21.7%5.2%0.5 $0.73 12/15/20221,190,000 shares $858,347.00 +111.3%6.7%0.6 $0.72 11/30/2022563,100 shares $385,779.81 +15.1%3.2%3.3 $0.69 11/15/2022489,300 shares $398,094.48 +21.0%2.8%3.1 $0.81 10/31/2022404,400 shares $369,540.72 +0.3%2.3%2.6 $0.91 10/15/2022403,300 shares $399,831.62 +3.9%2.3%2.6 $0.99 9/30/2022388,000 shares $376,398.80 -9.3%2.2%2.4 $0.97 9/15/2022427,800 shares $693,036.00 +3.0%2.4%2.3 $1.62 8/31/2022415,400 shares $689,564.00 -6.2%2.4%2.5 $1.66 8/15/2022442,900 shares $947,806.00 -14.9%2.5%2.2 $2.14 7/31/2022520,700 shares $1.02 million -7.8%3.0%2.2 $1.95 7/15/2022564,700 shares $1.42 million -7.0%3.2%2.3 $2.52Everybody laughed when he recommended Netflix (Ad)"This Could be Worth Even More than A.I." Whitney Tilson's nailed many of the most famous stocks of the last 25 years – including Netflix, Amazon, and Apple. Now he's pounding the table on a new technology rolling out across America, which early estimates say could create more wealth than A.I., the personal computer, and the smartphone combined. Click here to see how it could become the No. 1 investment of the next decade. 6/30/2022607,400 shares $1.16 million -49.0%3.5%2.1 $1.91 6/15/20221,190,000 shares $2.39 million +6.3%6.8%4 $2.01 5/31/20221,120,000 shares $2.31 million +4.7%6.4%3.7 $2.06 5/15/20221,070,000 shares $2.14 million -7.8%6.1%2.8 $2.00 4/30/20221,160,000 shares $2.61 million +7.4%6.6%3.3 $2.25 4/15/20221,080,000 shares $3.51 million +0.9%6.2%3.1 $3.25 3/31/20221,070,000 shares $5.32 million +8.9%6.1%3.2 $4.97 3/15/2022982,400 shares $3.52 million +15.7%5.5%2.9 $3.58 2/28/2022849,000 shares $3.48 million +0.4%4.8%2.7 $4.10 2/15/2022845,900 shares $4.79 million -1.3%4.8%3.5 $5.66 1/31/2022857,300 shares $4.54 million +17.0%4.8%3.4 $5.29 1/15/2022732,600 shares $4.29 million +2.7%N/A2.7 $5.85 12/31/2021713,200 shares $5.38 million -7.6%4.0%2.6 $7.55 12/15/2021771,800 shares $5.14 million -13.4%4.3%2.7 $6.66 11/30/2021891,100 shares $5.47 million -0.5%5.0%2.9 $6.14 11/15/2021895,600 shares $6.56 million +1.8%4.3%2.7 $7.33 10/29/2021879,800 shares $5.51 million -1.5%4.3%2.5 $6.26 10/15/2021892,900 shares $6.18 million +7.3%4.4%2.1 $6.92 9/30/2021832,000 shares $6.57 million -45.3%4.1%1.8 $7.90 9/15/20211,520,000 shares $13.01 million -40.6%7.4%3.1 $8.56 8/31/20212,560,000 shares $24.27 million +2.4%12.5%5.1 $9.48 8/13/20212,500,000 shares $22.43 million -10.7%12.1%4.9 $8.97 7/30/20212,800,000 shares $27.41 million +36.6%15.4%5.8 $9.79 7/15/20212,050,000 shares $25.07 million +4.6%10.0%5.4 $12.23 6/30/20211,960,000 shares $27.19 million +69.0%9.6%6.1 $13.87 6/15/20211,160,000 shares $17.67 million +35.4%5.7%3.9 $15.23 5/28/2021857,000 shares $17.67 million -8.1%4.2%3.3 $20.62 5/14/2021932,800 shares $18.47 million -11.2%4.6%3.9 $19.80 4/30/20211,050,000 shares $23.43 million -9.5%5.2%4.4 $22.31 4/15/20211,160,000 shares $23.90 million +9.4%5.9%4.7 $20.60 3/31/20211,060,000 shares $20.79 million +33.8%4.6%3.5 $19.61 3/15/2021792,500 shares $15.46 million +4.6%3.4%2.6 $19.51 2/26/2021757,800 shares $13.88 million +11.8%3.3%2.5 $18.31 2/12/2021678,000 shares $14.08 million -5.8%2.9%2.5 $20.77 1/29/2021719,700 shares $13.43 million -4.2%3.5%2.9 $18.66 1/15/2021751,500 shares $16.05 million -11.3%3.9%3.3 $21.36 12/31/2020847,500 shares $14.09 million +23.0%4.6%4.3 $16.63 12/15/2020688,800 shares $9.73 million -13.2%4.6%4.7 $14.13 11/30/2020793,700 shares $11.78 million -1.4%5.3%5.5 $14.84 11/15/2020804,900 shares $12.56 million -6.2%5.4%4.8 $15.60 10/30/2020858,500 shares $12.97 million -0.1%5.7%2.8 $15.11 10/15/2020859,500 shares $13.89 million -2.4%5.8%2.6 $16.16 9/30/2020880,600 shares $14.96 million +6.5%5.9%2.6 $16.99 9/15/2020826,600 shares $13.14 million +27.3%5.6%2.4 $15.90 8/31/2020649,200 shares $8.93 million -0.5%4.4%2 $13.76 8/14/2020652,700 shares $7.92 million +1.3%4.4%2 $12.13 7/31/2020644,300 shares $7.09 million +23.2%4.4%3.1 $11.01 7/15/2020522,900 shares $7.87 million +17.2%3.6%2.8 $15.06 6/30/2020446,300 shares $7.36 million +102.1%3.1%2.6 $16.49 6/15/2020220,800 shares $3.89 million +4.5%1.5%1.5 $17.64Everybody laughed when he recommended Netflix (Ad)"This Could be Worth Even More than A.I." Whitney Tilson's nailed many of the most famous stocks of the last 25 years – including Netflix, Amazon, and Apple. Now he's pounding the table on a new technology rolling out across America, which early estimates say could create more wealth than A.I., the personal computer, and the smartphone combined. Click here to see how it could become the No. 1 investment of the next decade. 5/29/2020211,300 shares $4.60 million -33.3%1.5%1.4 $21.76 5/15/2020316,700 shares $4.57 million +29.1%2.2%2.9 $14.43 4/30/2020245,300 shares $3.09 million -21.9%1.7%3 $12.60 4/15/2020314,100 shares $3.89 million +0.7%2.2%3.2 $12.40 3/31/2020311,900 shares $3.88 million +7.9%2.2%2.9 $12.43 3/13/2020289,000 shares $3.31 million +12.9%2.1%4.4 $11.47 2/28/2020256,100 shares $2.86 million +1.8%1.9%1.9 $11.15 2/14/2020251,600 shares $3.56 million -28.3%1.8%1.8 $14.16 1/31/2020351,000 shares $5.17 million +6.7%2.6%2.5 $14.73 1/15/2020329,000 shares $5.26 million +32.1%2.4%2.9 $15.98 12/31/2019249,100 shares $3.64 million +1.9%1.8%2.5 $14.62 8/15/2019180,000 shares $2.52 million -11.8%2.1%7.4 $13.99 HARP Short Interest - Frequently Asked Questions What is Harpoon Therapeutics' current short interest? Short interest is the volume of Harpoon Therapeutics shares that have been sold short but have not yet been closed out or covered. As of February 29th, investors have sold 538,400 shares of HARP short. 4.31% of Harpoon Therapeutics' shares are currently sold short. Learn More on Harpoon Therapeutics' current short interest. What is a good short interest percentage for Harpoon Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.31% of Harpoon Therapeutics' floating shares are currently sold short. Is Harpoon Therapeutics' short interest increasing or decreasing? Harpoon Therapeutics saw a decline in short interest in February. As of February 29th, there was short interest totaling 538,400 shares, a decline of 53.6% from the previous total of 1,160,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Harpoon Therapeutics' float size? Harpoon Therapeutics currently has issued a total of 16,932,000 shares. Some of Harpoon Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Harpoon Therapeutics currently has a public float of 12,500,000 shares. How does Harpoon Therapeutics' short interest compare to its competitors? 4.31% of Harpoon Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Harpoon Therapeutics: Terns Pharmaceuticals, Inc. (10.91%), LifeMD, Inc. (8.10%), ModivCare Inc. (7.13%), Aurora Cannabis Inc. (34.02%), Anika Therapeutics, Inc. (5.64%), Korro Bio, Inc. (2.68%), Cerus Co. (3.09%), Organogenesis Holdings Inc. (12.55%), Solid Biosciences Inc. (3.01%), Verrica Pharmaceuticals Inc. (14.05%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.39 billion), General Motors ($3.88 billion), Super Micro Computer, Inc. ($3.51 billion), Charter Communications, Inc. ($3.22 billion), Occidental Petroleum Co. ($3.13 billion), Tractor Supply ($2.76 billion), Coinbase Global, Inc. ($2.63 billion), Suncor Energy Inc. ($2.48 billion), Moderna, Inc. ($2.04 billion), and Royal Caribbean Cruises Ltd. ($1.87 billion). View all of the most shorted stocks. What does it mean to sell short Harpoon Therapeutics stock? Short selling HARP is an investing strategy that aims to generate trading profit from Harpoon Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Harpoon Therapeutics? A short squeeze for Harpoon Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of HARP, which in turn drives the price of the stock up even further. How often is Harpoon Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HARP, twice per month. The most recent reporting period available is February, 29 2024. More Short Interest Resources from MarketBeat Related Companies: Terns Pharmaceuticals Short Interest LifeMD Short Interest ModivCare Short Interest Aurora Cannabis Short Interest Anika Therapeutics Short Interest Korro Bio Short Interest Cerus Short Interest Organogenesis Short Interest Solid Biosciences Short Interest Verrica Pharmaceuticals Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:HARP) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldBiden Nomination CANCELED?The Freeport SocietyDoes this make you sick?Allegiance GoldDems have chosen Biden replacement?Paradigm PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsThis Could be Your “Big Money” AI MomentInvestorPlace